Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Fuith

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Clinical Chemistry|September 1, 1996
Neopterin concentrations in vaginal secretionsL C Fuith, M Czarnecki, H Wachter, et al.
American Journal of Obstetrics and Gynecology|September 1, 1991
Prognostic value of CA 125 and neopterin in women with ovarian cancer undergoing second-look laparotomyL C Fuith, D Fuchs, G Reibnegger, et al.
Gynakologische Rundschau|January 1, 1988
[Ovarian cancer cells and interferon: aspects of a biological network]C Marth, M Brattia, L C Fuith, et al.
British Journal of Anaesthesia|January 1, 1988
Safe use of propofol in a patient with acute intermittent porphyriaG Mitterschiffthaler, A Theiner, H Hetzel, et al.
Lancet (London, England)|November 19, 1988
Screening for toxoplasmosis in pregnancyL C Fuith, G Reibnegger, M Hönlinger, et al.
Wiener Klinische Wochenschrift|May 12, 1989
[Severe bacterial infections in gynecology and obstetrics]L C Fuith, W Reider, P Mayr, et al.
Obstetrics and Gynecology|May 1, 1994
Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancerL C Fuith, M Czarnecki, H Wachter, et al.
Gynakologische Rundschau|January 1, 1989
[Preoperative risk assessment of cancer patients]G Mitterschiffthaler, B Reitter, L C Fuith, et al.
Lancet (London, England)|June 27, 1992
Mode of delivery in HIV-1-infected womenL C Fuith, M Czarnecki, H Wachter, et al.
Lancet (London, England)|April 22, 1989
Cellular immune activation and erythropoiesis in gynaecological cancerL C Fuith, D Fuchs, G Reibnegger, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Clinical Chemistry|September 1, 1996
Neopterin concentrations in vaginal secretionsL C Fuith, M Czarnecki, H Wachter, et al.
American Journal of Obstetrics and Gynecology|September 1, 1991
Prognostic value of CA 125 and neopterin in women with ovarian cancer undergoing second-look laparotomyL C Fuith, D Fuchs, G Reibnegger, et al.
Gynakologische Rundschau|January 1, 1988
[Ovarian cancer cells and interferon: aspects of a biological network]C Marth, M Brattia, L C Fuith, et al.
British Journal of Anaesthesia|January 1, 1988
Safe use of propofol in a patient with acute intermittent porphyriaG Mitterschiffthaler, A Theiner, H Hetzel, et al.
Lancet (London, England)|November 19, 1988
Screening for toxoplasmosis in pregnancyL C Fuith, G Reibnegger, M Hönlinger, et al.
Wiener Klinische Wochenschrift|May 12, 1989
[Severe bacterial infections in gynecology and obstetrics]L C Fuith, W Reider, P Mayr, et al.
Obstetrics and Gynecology|May 1, 1994
Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancerL C Fuith, M Czarnecki, H Wachter, et al.
Gynakologische Rundschau|January 1, 1989
[Preoperative risk assessment of cancer patients]G Mitterschiffthaler, B Reitter, L C Fuith, et al.
Lancet (London, England)|June 27, 1992
Mode of delivery in HIV-1-infected womenL C Fuith, M Czarnecki, H Wachter, et al.
Lancet (London, England)|April 22, 1989
Cellular immune activation and erythropoiesis in gynaecological cancerL C Fuith, D Fuchs, G Reibnegger, et al.
Pageof 7